With signs of promising efficacy among the candidate COVID-19 vaccines, the public anxiously awaits the vaccine to slow the pandemic and help restore our usual ways of life. Yet uncertainty remains on how once-approved vaccines will reach the public. Will vaccines be able to meet the global demand? How can we ensure equitable distribution so that the vaccine is accessible to those at greatest risk?
The panelists will share their perspectives on these challenging questions and provide insight into what safe, rapid, and equitable COVID-19 vaccine distribution could look like.
- Seth Berkley, Gavi: The Vaccine Alliance
- Peggy Hamburg, National Academy of Medicine
- Gregg Gonsalves, Yale School of Medicine; Yale Law School